Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Vor Biopharma (VOR)
NASDAQ:VOR
Vor Biopharma (VOR) Stock Price & Analysis
127 Followers
VOR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.05 - $7.57
Previous Close$2.1
Volume75.52K
Average Volume (3M)103.14K
Market Cap
$141.83M
Enterprise ValueN/A
Total Cash (Recent Filing)$186.90M
Total Debt (Recent Filing)$37.51M
Price to Earnings (P/E)-1.0
Beta0.45
Next Earnings
Nov 09, 2023EPS Estimate
-$0.47Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.02
Shares Outstanding67,538,680
10 Day Avg. Volume82,863
30 Day Avg. Volume103,138
Standard Deviation0.20
R-Squared0.05
Alpha-0.07
Financial Highlights & Ratios
Price to Book (P/B)0.70
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$15.75Price Target Upside642.92% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
Vor Biopharma News
Press ReleasesVor Bio to Participate in Upcoming Investor Conferences
Press ReleasesVor Bio to Participate in Upcoming Investor Conferences
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
VOR FAQ
What was Vor Biopharma’s price range in the past 12 months?
Vor Biopharma lowest stock price was $2.05 and its highest was $7.57 in the past 12 months.
What is Vor Biopharma’s market cap?
Currently, no data Available
When is Vor Biopharma’s upcoming earnings report date?
Vor Biopharma’s upcoming earnings report date is Nov 09, 2023 which is in 41 days.
How were Vor Biopharma’s earnings last quarter?
Vor Biopharma released its earnings results on Aug 10, 2023. The company reported -$0.45 earnings per share for the quarter, missing the consensus estimate of -$0.421 by -$0.029.
Is Vor Biopharma overvalued?
According to Wall Street analysts Vor Biopharma’s price is currently Undervalued.
Does Vor Biopharma pay dividends?
Vor Biopharma does not currently pay dividends.
What is Vor Biopharma’s EPS estimate?
Vor Biopharma’s EPS estimate is -$0.47.
How many shares outstanding does Vor Biopharma have?
Vor Biopharma has 67,538,680 shares outstanding.
What happened to Vor Biopharma’s price movement after its last earnings report?
Vor Biopharma reported an EPS of -$0.45 in its last earnings report, missing expectations of -$0.421. Following the earnings report the stock price went up 14.397%.
Which hedge fund is a major shareholder of Vor Biopharma?
Among the largest hedge funds holding Vor Biopharma’s share is RA Capital Management. It holds Vor Biopharma’s shares valued at 70M.
---
Vor Biopharma Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$15.75 (642.92% Upside)
$15.75 (642.92% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 1.8%
Last 30 Days ▼ 1.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-48.90%
12-Months-Change
Fundamentals
Return on Equity
-55.93%
Trailing 12-Months
Asset Growth
11.74%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Vor Biopharma
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies.
---
Top 5 ETFs holding VOR
Vanguard Total Stock Market ETF
$2.48M
Vanguard Russell 3000 ETF
$5.79K
Up to five ETFs with an Outperform Smart Score that hold VOR. The ETFs are listed according to market value of VOR within the ETF
---